Akari Therapeutics (AKTX) Beginning Cash Balance (2014 - 2015)
Akari Therapeutics recorded quarterly Beginning Cash Balance of $4.1 million in Q4 2015, up 56587.88% quarter-over-quarter from -$7205.0 in Q4 2014, and up 56587.88% year-over-year from N/an in Q4 2014.
Akari Therapeutics' Beginning Cash Balance history runs 2 years deep, the most recent figure standing at $4.1 million for Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 4.07 Mn |
| Dec 31, 2015 | 4.07 Mn |
| Dec 31, 2014 | -7,205.00 |
| Dec 31, 2014 | -7,205.00 |